Results 51 to 60 of about 42,495 (262)

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease

International Journal of Cardiology: Heart & Vasculature
Background: Atrial fibrillation (AF) screening should be considered in elderly patients with high risk of stroke, which include individuals with hypertension.
Gina Sado, Katrin Kemp Gudmundsdottir, Carl Bonander, Mattias Ekström, Johan Engdahl, Emma Svennberg   +5 more
doaj   +1 more source

The integration of BNP and NT-proBNP into clinical medicine

Swiss Medical Weekly, 2007
B-type natriuretic peptide (BNP) and NTproBNP have been shown to be extremely helpful in the diagnosis and management of patients with heart failure (HF). These neurohormones are predominately secreted from the left and the right cardiac ventricle in response to volume and pressure overload.
Christian, Mueller, Tobias, Breidthardt, Kirsten, Laule-Kilian, Michael, Christ, André P, Perruchoud   +4 more
openaire   +3 more sources

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

Heart Failure With Preserved Ejection Fraction and Lower Natriuretic Peptide: Clinical Characteristics and Change in Natriuretic Peptide Levels

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Recent heart failure (HF) guidelines emphasize the importance of recognizing patients with mild elevations in NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide).
Kanako Teramoto, Kotaro Nochioka, Yasuhiko Sakata, Kunihiro Nishimura, Hiroaki Shimokawa, Satoshi Yasuda   +5 more
doaj   +1 more source

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki, Tetsu Watanabe, Mari Shimizu, Shingo Tachibana, Junya Sato, Yuta Kobayashi, Harutoshi Tamura, Shigehiko Kato, Satoshi Nishiyama, Hiroki Takahashi, Takanori Arimoto, Masafumi Watanabe   +11 more
wiley   +1 more source

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

ESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler, Malcolm Brown, Philippe Prokocimer, Ashley C. Humphries, Sophie Pope, Olivia Wright, Jun Su, Osama Elnawasany, Bogdan Muresan   +8 more
wiley   +1 more source

NT-proBNP for risk stratification of pulmonary embolism

Revista Portuguesa de Cardiologia (English Edition), 2011
Pulmonary embolism (PE) is an entity with high mortality and morbidity, in which risk stratification for adverse events is essential. N-terminal brain natriuretic peptide (NT-proBNP), a right ventricular dysfunction marker, may be useful in assessing the short-term prognosis of patients with PE.To characterize a sample of patients hospitalized with PE ...
Hélder, Dores, Cândida, Fonseca, Sílvio, Leal, Ingrid, Rosário, João, Abecasis, José, Monge, Maria João, Correia, Luís, Bronze, Ana, Leitão, Isabel, Arroja, Ana, Aleixo, Aniceto, Silva   +11 more
openaire   +2 more sources

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

冠心病患者NT-ProBNP与HS-CRP联合检测的临床意义

Zhongguo shiyan zhenduanxue, 2006
目的探讨冠心病患者中NT-proBNP与hs-CRP联合检测的临床意义。方法收集临床上冠心病患者并进行分组,其中AMI组25例,UA组20例,SA组25例;正常对照组10例,所有患者入院后均即刻进行NT-proBNP与hs-CRP的检测,并根据NT-proBNP与hs-CRP高低再进一步将所有患者分成低NT-proBNP/低hs-CRP;低NT-proBNP/高hs-CRP;高NT-proBNP/低hs-CRP;高NT-proBNP/高hs-CRP四组。结果高NT-proBNP/高hs ...
宋春莉, 刘斌, 费瑜, 陈宏勃
doaj  

Baseline NT-proBNP levels as a predictor of short-and long-term prognosis in COVID-19 patients: a prospective observational study

BMC Infectious Diseases
Background Up to 20% of COVID-19 patients can suffer COVID-19-related myocardial injury. Elevated cardiac biomarkers, such as hs-cTnT and NT-proBNP, have been related to worse short-term prognosis.
Diana Mojón-Álvarez, Teresa Giralt, José Carreras-Mora, Alicia Calvo-Fernández, Andrea Izquierdo, Cristina Soler, Paula Cabero, Silvia Pérez-Fernández, Beatriz Vaquerizo, Núria Ribas Barquet   +9 more
doaj   +1 more source